PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients-Reference-Cited by-同舟云学术

PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients

Published:2001-08-27 Issue:1 Volume:29 Page:23-24
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Barcellos Lisa F.,Caillier Stacy,Dragone Leonard,Elder Melissa,Vittinghoff Eric,Bucher Patricia,Lincoln Robin R.,Pericak-Vance Margaret,Haines Jonathan L.,Weiss Arthur,Hauser Stephen L.,Oksenberg Jorge R.

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng722z.pdf

Reference9 articles.

1. Oksenberg, J.R., Baranzini, S.E., Barcellos, L.F. & Hauser, S.L. J. Neuroimmunol. 113, 171–184 (2001).

2. Jacobsen, M. et al. Nature Genet. 26, 495–499 (2000).

3. Goodkin, D. et al. Arch. Neurol. 48, 805–807 (1991).

4. Barcellos, L.F. et al. Brain (in the press).

5. Martin, E.R., Monks, S.A., Warren, L.L. & Kaplan, N.L. Am. J. Hum. Genet. 67, 146–154 (2000).

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential proteins and microRNAs in Multiple Sclerosis and Huntington’s diseases using in silico methods;2021-09-21

2. Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy;Frontiers in Cell and Developmental Biology;2020-12-09

3. Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis;Frontiers in Oncology;2020-07-31

4. CD45 in human physiology and clinical medicine;Immunology Letters;2018-04

5. C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease;PLOS ONE;2017-07-31